| Literature DB >> 36204479 |
Ryan Chow1, Eileen Huang1, Sarah Fu1, Eileen Kim1, Sophie Li1, Jasmine Sodhi2, Togas Tulandi3, Kelly D Cobey4, Vanessa Bacal5,6, Innie Chen6,7,8.
Abstract
Objectives: The objective of this study was to evaluate the extent, type, and severity of spin in randomized controlled trials (RCTs) in obstetrics and gynecology. Data Sources: The top five highest impact journals in obstetrics and gynecology were systematically searched for RCTs with non-significant primary outcomes published between January 1, 2019, and December 31, 2020.Entities:
Keywords: RCTs; gynecology; interpretive bias; methodology; obstetrics; reporting
Year: 2022 PMID: 36204479 PMCID: PMC9531885 DOI: 10.1089/whr.2021.0141
Source DB: PubMed Journal: Womens Health Rep (New Rochelle) ISSN: 2688-4844
Characteristics of Included Studies, Randomized Trials in Obstetrics and Gynecology Literature, January 2019 to December 2020
| Trial characteristic | Median [range]/ |
|---|---|
| Total | 59 |
| Journal Impact Factor | 5.51 [4.62–6.12] |
| No. of citations up to July 2020 | 2 [0–13] |
| Year of publication | |
| 2019[ | 30 (51) |
| 2020[ | 29 (49) |
| Research area | |
| Obstetrics | 22 (37) |
| Gynecology | 37 (63) |
| Experimental arm | |
| Device or drug | 33 (56) |
| Participative intervention[ | 5 (8) |
| Novel care pathway | 21 (36) |
| Comparator arm | |
| Comparator device or drug | 7 (12) |
| Comparator participative intervention | 2 (3) |
| Placebo | 20 (33) |
| Standard care | 30 (51) |
| Funding source | |
| Government | 9 (15) |
| Other public institution | 28 (47) |
| Industry | 14 (24) |
| Funding not stated | 8 (14) |
| No. of authors | |
| 1–8 | 40 (68) |
| 9+ | 19 (32) |
January 1 to December 31, 2019.
January 1 to December 31, 2020.
Initiative that focuses on patient participation, for example, exercise or education.
FIG. 1.PRISMA flow diagram for study selection, randomized trials in obstetrics and gynecology literature, January 2019 to December 2020. 1475 publications were identified, of which 96 (6.5%) were duplicates. Seventy-nine (5.3%) titles and abstracts passed initial title and abstract screening, and full-text articles were retrieved. Six (0.41%) articles were excluded, as they had statistically significant primary outcomes. Fourteen (0.95%) articles were excluded, as they did not have 1:1 parallel, two-arm study designs. A total of 59 (4.0%) studies met the inclusion criteria. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analyses.
Extent (Frequency) of Spin by Study Characteristics, Randomized Trials in Obstetrics and Gynecology Literature, January 2019 to December 2020
| Spin frequency | Spin absent | Spin present—No. of occurrence(s) | |||
|---|---|---|---|---|---|
| One | Two | Three or more | |||
| Median, [range] | |||||
| Total | 0 [0–5] | 28 (46) | 3 (5) | 10 (17) | 18 (19) |
| Year of publication | |||||
| 2019 | 1 [0–5] | 14 (24) | 2 (3) | 8 (14) | 6 (10) |
| 2020 | 0 [0–4] | 14 (22) | 1 (2) | 2 (3) | 12 (20) |
| Research area | |||||
| Obstetrics | 0 [0–5] | 11 (19) | 1 (2) | 5 (8) | 5 (8) |
| Gynecology | 0 [0–4] | 17 (29) | 2 (3) | 5 (8) | 13 (22) |
| Experimental arm | |||||
| Device or drug | 0 [0–5] | 15 (25) | 2 (3) | 4 (7) | 12 (20) |
| Participative intervention | 0 [0–3] | 3 (5) | 0 (0) | 2 (3) | 0 (0) |
| Novel care pathway | 1 [0–3] | 10 (17) | 1 (2) | 4 (7) | 6 (10) |
| Comparator arm | |||||
| Comparator device or drug | 1 [0–5] | 2 (3) | 1 (2) | 1 (2) | 3 (5) |
| Comparator participative intervention | 1.5 [0–3] | 1 (2) | 0 (0) | 0 (0) | 1 (2) |
| Placebo | 0 [0–4] | 11 (19) | 0 (0) | 5 (5) | 4 (3) |
| Standard care | 1 [0–3] | 13 (22) | 2 (3) | 4 (7) | 10 (12) |
| Funding | |||||
| Government | 0 [0–3] | 6 (10) | 0 (0) | 2 (3) | 1 (2) |
| Other public institution | 0 [0–3] | 14 (24) | 2 (3) | 4 (7) | 8 (14) |
| Industry | 0.5 [0–4] | 5 (8) | 1 (2) | 0 (0) | 8 (14) |
| Funding not stated | 2 [0–3] | 3 (5) | 0 (0) | 4 (7) | 1 (2) |
| No. of authors | |||||
| 1–8 | 0 [0–3] | 20 (34) | 3 (5) | 7 (12) | 10 (20) |
| 9 or more | 0 [0–5] | 8 (14) | 0 (0) | 3 (5) | 8 (10) |
| Cochrane Risk-of-Bias Assessment | |||||
| Bias due to randomization | 1 [0–4] | 5 (8) | 0 (0) | 1 (2) | 4 (7) |
| No bias due to randomization | 2.5 [0–5] | 23 (39) | 3 (5) | 9 (15) | 14 (24) |
| Bias due to missing data[ | 2 [0–5] | 6 (10) | 2 (3) | 7 (12) | 6 (10) |
| No bias due to missing data | 2 [0–5] | 22 (37) | 1 (2) | 3 (6) | 12 (20) |
| Bias in selection of reported outcomes | 2 [0–5] | 11 (19) | 1 (2) | 6 (10) | 8 (14) |
| No bias in selection of reported outcomes | 2.5 [0–5] | 17 (29) | 2 (3) | 4 (5) | 10 (17) |
| Overall risk of bias | 1.5 [0–5] | 18 (31) | 2 (3) | 9 (15) | 11 (19) |
| No risk of bias | 1 [0–2] | 10 (17) | 1 (2) | 1 (2) | 7 (12) |
p < 0.05.
Type of Spin According to Section of Article, Randomized Trials in Obstetrics and Gynecology Literature, January 2019 to December 2020
| Type of spin in each section | Full article, | Abstract, | Main text, |
|---|---|---|---|
| Results | |||
| No spin | 40 (67) | 40 (67) | 42 (71) |
| Focus on secondary outcomes | 13 (22) | 12 (20) | 8 (14) |
| Focus on subgroup analysis | 6 (10) | 3 (5) | 6 (10) |
| Discussion | |||
| No spin | — | — | 38 (64) |
| Focus on secondary outcomes | — | — | 12 (20) |
| Focus on subgroup analysis | — | — | 7 (12) |
| Conclusion | |||
| No spin | 32 (54) | 38 (64) | 3 (5) |
| Focus on secondary outcomes | 13 (22) | 8 (14) | 9 (15) |
| Claiming treatment equivalence | 6 (10) | 5 (8) | 3 (5) |
| Acknowledging nonsignificant results for primary outcome, but focusing on beneficial effect of treatment | 6 (10) | 3 (5) | 5 (8) |
| Claiming efficacy despite nonsignificant results | 2 (3) | 1 (2) | 1 (2) |
| Extent of spin[ | |||
| None | — | 37 (63) | 32 (54) |
| Low | — | 11 (19) | 10 (17) |
| Medium | — | 6 (10) | 5 (8) |
| High | — | 5 (8) | 11 (19) |
| Severity of spin[ | |||
| None | — | 36 (61) | 31 (53) |
| Low | — | 19 (32) | 20 (34) |
| Medium | — | 1 (2) | 8 (14) |
| High | — | 3 (5) | 0 (0) |
Extent of spin refers to the number of sections where spin occurs. Low: spin in one section other than the conclusion section. Medium: spin in the conclusion section only, or in two sections of the main text. High: spin identified in all sections of the main text.
Severity of spin describes the severity of spin present. Low: the acknowledgment of the nonsignificant primary outcome and that future research would be beneficial. Moderate: lack of acknowledgment of the nonsignificant primary outcome, with some ambivalence regarding recommendations for future research. High: lack of acknowledgment of the nonsignificant primary outcome and no recommendations for future research.